EP2086982
HCV NS3 PROTEASE INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.10.2007EP published:
29.8.2018EP application number:
07839746.0
EPO information:
European Patent Register
Max expiry date:
22.10.2027
Title:
HCV NS3 PROTEASE INHIBITORS
Timeline
Today
23.10.2007EP application
29.8.2018EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, 07065-0907, Rahway, NJ, US
Name:
MSD Italia S.r.l.Address:
Via Vitorchiano, 151, 00189, Rome, IT
Inventor
Name:
LIVERTON, Nigel J.Address:
Rahway, NJ, US
Name:
SUMMA, VincenzoAddress:
Pomezia (Rome), IT
Name:
DI FRANCESCO, Maria EmiliaAddress:
Pomezia (Rome), IT
Name:
FERRARA, MarcoAddress:
Pomezia (Rome), IT
Name:
GILBERT, Kevin F.Address:
Rahway, NJ, US
Name:
HARPER, StevenAddress:
Pomezia (Rome), IT
Name:
MCCAULEY, John A.Address:
Rahway, NJ, US
Name:
MCINTYRE, Charles J.Address:
Rahway, NJ, US
Name:
PETROCCHI, AlessiaAddress:
Pomezia (Rome), IT
Name:
POMPEI, MarcoAddress:
Pomezia (Rome), IT
Name:
ROMANO, Joseph J.Address:
Rahway, NJ, US
Name:
RUDD, Michael T.Address:
Rahway, NJ, US
Name:
HOLLOWAY, M KatharineAddress:
West Point, PA, US
Name:
Butcher, John WAddress:
West Point, PA, US
Priority
Number:
854912 PDate:
27.10.2006Country:
US
Number:
997434 PDate:
3.10.2007Country:
US
Classification
Categories:
C07D 498/08, C07D 498/18, C07K 5/08, C07K 5/10, C07K 5/12, A61K 31/40, A61K 38/06, A61K 38/07, A61K 31/12